|
C7ORF70 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.118700E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.275800E-02 |
| Normal-vs-Stage2 |
3.757600E-01 |
| Normal-vs-Stage3 |
6.224300E-02 |
| Normal-vs-Stage4 |
1.308760E-01 |
| Stage1-vs-Stage2 |
8.715200E-01 |
| Stage1-vs-Stage3 |
3.182600E-01 |
| Stage1-vs-Stage4 |
3.720000E-01 |
| Stage2-vs-Stage3 |
3.648200E-01 |
| Stage2-vs-Stage4 |
2.981200E-01 |
| Stage3-vs-Stage4 |
8.392200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.523300E-03 |
| Normal-vs-AfricanAmerican |
1.794990E-01 |
| Normal-vs-Asian |
2.972800E-01 |
| Caucasian-vs-AfricanAmerican |
4.091600E-01 |
| Caucasian-vs-Asian |
4.670200E-01 |
| AfricanAmerican-vs-Asian |
2.942400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.557900E-02 |
| Normal-vs-Female |
4.174900E-04 |
| Male-vs-Female |
1.696140E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.012400E-01 |
| Normal-vs-Extreme_Weight |
3.040300E-02 |
| Normal-vs-Obese |
1.598440E-02 |
| Normal-vs-Extreme_Obese |
8.963400E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.132800E-01 |
| Normal_Weight-vs-Obese |
1.215750E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.897200E-01 |
| Extreme_Weight-vs-Obese |
7.297800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.034200E-01 |
| Obese-vs-Extreme_Obese |
2.169400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.135300E-03 |
| Normal-vs-Age(41-60Yrs) |
1.359320E-03 |
| Normal-vs-Age(61-80Yrs) |
1.738850E-01 |
| Normal-vs-Age(81-100Yrs) |
8.488200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.598100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.020000E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.734100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.278400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.514200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.428400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.899230E-03 |
| Normal-VS-Type2 PRCC |
9.729800E-01 |
| Normal-VS-KIRP CIMP |
2.042300E-02 |
| Normal-VS-Unclassified PRCC |
3.674300E-02 |
| Type1 PRCC-VS-Type2 PRCC |
8.780900E-03 |
| Type1 PRCC-VS-KIRP CIMP |
5.215800E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
7.339200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.920450E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
3.224000E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.943900E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.119200E-01 |
| Normal-vs-N1 |
1.529890E-02 |
| Normal-vs-N2 |
3.655200E-03 |
| N0-vs-N1 |
1.344150E-02 |
| N0-vs-N2 |
3.169700E-02 |
| N1-vs-N2 |
8.631000E-01 |
|
|
